Physician profile
Mary K Deka
NPI 1225232838
$3,867.05
in general payments reported to CMS, 2019-2025
36 companies · $771 in 2025
The $771 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,051 · 2020: $441 · 2021: $97.72 · 2022: $399 · 2023: $518 · 2024: $589 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,878.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $769.56 | 2019-2024 | |
| Hologic Sales and Service, LLC | $319.52 | 2019-2025 | Myosure Tissue Removal Device, Novasure, Aptima |
| Astellas Pharma US INC | $259.43 | 2023-2025 | Veozah |
| Organon LLC | $216.28 | 2021-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $206.86 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $198.74 | 2022-2025 | |
| Exeltis, USA INC. | $179.90 | 2019-2025 | Slynd |
| Ethicon US, LLC | $163.91 | 2020-2025 | Ethicon, Stratafix, Dermabond Prineo |
| Coopersurgical, INC. | $160.96 | 2021-2025 | Paragard T 380a, Paragard T 380a, Summit Doppler |
| Abbvie INC. | $154.74 | 2019-2022 | |
| Shield Therapeutics INC | $151.00 | 2024-2025 | |
| Millicent US INC | $141.92 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Therapeuticsmd, INC. | $127.29 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $115.51 | 2019-2023 | Gardasil 9 |
| Biogen, INC. | $107.40 | 2024-2025 | Zurzuvae |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $85.58 | 2023-2025 | Ova1 |
| Channel Medsystems, INC. | $60.64 | 2022 | |
| Pfizer INC. | $41.59 | 2025 | |
| Duchesnay USA Incorporated | $40.47 | 2019 | |
| Mission Pharmacal Company | $32.08 | 2019-2023 | Citranatal |
| Seqirus USA INC | $31.52 | 2025 | Flucelvax |
| Avion Pharmaceuticals | $29.64 | 2020-2023 | Balcoltra |
| Covidien LP | $29.31 | 2019 | |
| Daiichi Sankyo INC. | $28.02 | 2019 | |
| Amag Pharmaceuticals, INC. | $26.35 | 2019 | |
| Allergan, INC. | $23.53 | 2019 | |
| Exact Sciences Corporation | $21.45 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $20.75 | 2023 | Wegovy |
| Dexcom, INC. | $17.30 | 2025 | Dexcom G6 Transmitter |
| Gynesonics, INC. | $16.63 | 2022 | |
| Medicem INC. | $16.19 | 2023 | |
| Olympus America INC. | $16.09 | 2024 | Olympus |
| Meditrina | $16.02 | 2025 | |
| Myovant Sciences INC. | $15.81 | 2022 | |
| Itamar Medical INC | $13.42 | 2025 | Watchpatone |
| Sage Therapeutics, LLC | $11.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Deka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.